Effect of Chemokine Gene Variants on Covid-19 Disease Severity

References

• Bernas SN, Baldauf H, Wendler S, Heidenreich F, Lange V, Hofmann JA, Sauter J, Schmidt AH, Schetelig J. 2021. CCR5Δ32 mutations do not determine COVID-19 disease course. Int J Infect Dis. 105:653–55.
   PubMedGoogle Scholar
• Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz D, Perlman S. 2016. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe. 19(2):181–93.
   PubMed Web of Science ®Google Scholar
• Channappanavar R, Perlman S. 2017. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 39(5):529–39.
   PubMed Web of Science ®Google Scholar
• Cuesta-Llavona E, Gómez J, Albaiceta GM, Amado-Rodríguez L, García-Clemente M, Gutiérrez-Rodríguez J, López-Alonso I, Hermida T, Enríquez AI, Hernández-González C, et al. 2021. Variant-Genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity. Int Immunopharmacol. 98:107825.
   PubMedGoogle Scholar
• Dasdemir S, Kucukali CI, Bireller ES, Tuzun E, Cakmakoglu B. 2016. Chemokine gene variants in schizophrenia. Nord J Psychiatry. 70(6):407–12.
   PubMed Web of Science ®Google Scholar
• Fehr AR, Perlman S. 2015. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 1282:1–23.
   PubMedGoogle Scholar
• Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet 2020 Jan 30]. Lancet. 395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Hubacek JA, Dusek L, Majek O, Adamek V, Cervinkova T, Dlouha D, Pavel J, Adamkova V. 2021. Ccr5delta32 deletion as a protective factor in Czech first-wave COVID-19 subjects. Physiol Res. 70(1):111–15.
   PubMedGoogle Scholar
• Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, Buchbinder SP, Coutinho RA, Eugen-Olsen J, Gallart T, Katzenstein TL, et al. 2001. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3’A alleles on HIV-1 disease progression: an international meta-analysis of individual-patient data. Ann Intern Med. 135(9):782–95.
   PubMedGoogle Scholar
• Kim ES, Choe PG, Park WB, Oh HS, Kim EJ, Nam EY, Na SH, Kim M, Song K-H, Bang JH, et al. 2016. Clinical progression and cytokine profiles of middle east respiratory syndrome coronavirus infection. J Korean Med Sci. 31(11):1717–25.
   PubMedGoogle Scholar
• Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. 2020. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 31(5):1003–08.
   PubMed Web of Science ®Google Scholar
• Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X, et al. 2020. Coronavirus infections and immune responses. J Med Virol. 92(4):424–32.
   PubMed Web of Science ®Google Scholar
• Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, Alanio C, Kuri-Cervantes L, Pampena MB, D’-Andrea K, et al. 2020. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 369(6508):eabc8511.
   PubMed Web of Science ®Google Scholar
• Miyagishi R, Niino M, Fukazawa T, Yabe I, Kikuchi S, Tashiro K. 2003. C-C chemokine receptor 2 gene polymorphism in Japanese patients with multiple sclerosis. J Neuroimmunol. 145(1–2):135–38.
   PubMedGoogle Scholar
• Pairo-Castineira E, Clohisey S, Klaric L, Bretherick AD, Rawlik K, Pasko D, Walker S, Parkinson N, Fourman MH, Russell CD, et al. 2021. Genetic mechanisms of critical illness in COVID-19. Nature. 591(7848):92–98.
   PubMed Web of Science ®Google Scholar
• Patterson BK, Seethamraju H, Dhody K, Corley MJ, Kazempour K, Lalezari JP, Pang AP, Sugai C, Francisco EB, Pise A, et al. 2020. Disruption of the CCL5/RANTES-CCR5 pathway restores immune homeostasis and reduces plasma viral load in critical COVID-19. Preprint. medRxiv. 2020.05.02.20084673. [accessed 2020 May 5]. doi:10.1101/2020.05.02.20084673
   Google Scholar
• Raskin S. 2020. Genetics of COVID-19. J Pediatr (Rio J). 97(4):378–86. doi:10.1016/j.jped.2020.09.002
   PubMedGoogle Scholar
• Rovin BH, Lu L, Saxena R. 1999. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun. 259(2):344–48.
   PubMed Web of Science ®Google Scholar
• Scheller J, Rose-John S. 2006. Interleukin-6 and its receptor: from bench to bedside. Med Microbiol Immunol. 195(4):173–83.
   PubMed Web of Science ®Google Scholar
• Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. 2020. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 20(6):363–74.
   PubMed Web of Science ®Google Scholar
• Wu L, Zhu J, Liu D, Sun Y, Wu C. 2021. An integrative multiomics analysis identifies putative causal genes for COVID-19 severity. Genet Med. 23(11):2076–86.
   PubMedGoogle Scholar
• Xi X, Guo Y, Zhu M, Wei Y, Li G, Du B, Wang Y. 2021. Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling. Virol J. 18(1):12. [accessed 2021 Jan 7]. doi:10.1186/s12985-020-01478-9
   PubMedGoogle Scholar
• Xiong Y, Liu Y, Cao L, Wang D, Guo M, Jiang A, Guo D, Hu W, Yang J, Tang Z, et al. 2020. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerg Microbes Infect. 9(1):761–70.
   PubMed Web of Science ®Google Scholar
• Yang Y, Shen C, Li J, Yuan J, Wei J, Huang F, Wang F, Li G, Li Y, Xing L, et al. 2020. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J Allergy Clin Immunol. 146(1):119–27.e4.
   PubMed Web of Science ®Google Scholar
• Zemans RL, Colgan SP, Downey GP. 2009. Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury. Am J Respir Cell Mol Biol. 40(5):519–35.
   PubMed Web of Science ®Google Scholar
• Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S, et al. 2020. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 81(2):e16–e25.
   PubMed Web of Science ®Google Scholar